Your search returned 23 results.

Results
	1.	Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. [electronic resource] by Pfeffer, Gerald Burke, Ailbhe Yu-Wai-Man, Patrick Compston, D Alastair S Chinnery, Patrick F Producer: 20140210 In: Neurology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis. [electronic resource] by Thompson, Sara A J Jones, Joanne L Cox, Amanda L Compston, D Alastair S Coles, Alasdair J Producer: 20100614 In: Journal of clinical immunology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Immune competence after alemtuzumab treatment of multiple sclerosis. [electronic resource] by McCarthy, Claire L Tuohy, Orla Compston, D Alastair S Kumararatne, Dinakantha S Coles, Alasdair J Jones, Joanne L Producer: 20131122 In: Neurology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. [electronic resource] by Williams-Gray, Caroline H Goris, An Saiki, Misuzu Foltynie, Thomas Compston, D Alastair S Sawcer, Stephen J Barker, Roger A Producer: 20090810 In: Journal of neurology vol. 256 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? [electronic resource] by Cerqueira, João J Compston, D Alastair S Geraldes, Ruth Rosa, Mario M Schmierer, Klaus Thompson, Alan Tinelli, Michela Palace, Jacqueline Producer: 20191003 In: Journal of neurology, neurosurgery, and psychiatry vol. 89 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation. [electronic resource] by Sajic, Marija Hunt, David P J Lee, Woojin Compston, D Alastair S Schweimer, Judith V Gregson, Norman A Chandran, Siddharthan Smith, Kenneth J Producer: 20120803 In: PloS one vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. [electronic resource] by Coles, Alasdair J Compston, D Alastair S Selmaj, Krzysztof W Lake, Stephen L Moran, Susan Margolin, David H Norris, Kim Tandon, P K Producer: 20081030 In: The New England journal of medicine vol. 359 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease. [electronic resource] by Williams-Gray, Caroline H Goris, An Foltynie, Thomas Brown, Joanne Maranian, Melanie Walton, Amie Compston, D Alastair Sawcer, Stephen J Barker, Roger A Producer: 20061018 In: Movement disorders : official journal of the Movement Disorder Society vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. [electronic resource] by Cox, Amanda L Thompson, Sara A J Jones, Joanne L Robertson, Vicki H Hale, Geoff Waldmann, Herman Compston, D Alastair S Coles, Alasdair J Producer: 20051229 In: European journal of immunology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. [electronic resource] by Coles, Alasdair J Cox, Amanda Le Page, Emmanuelle Jones, Joanne Trip, S Anand Deans, Jackie Seaman, Shaun Miller, David H Hale, Geoff Waldmann, Herman Compston, D Alastair Producer: 20060929 In: Journal of neurology vol. 253 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Association of the human leucocyte antigen region with susceptibility to Parkinson's disease. [electronic resource] by Saiki, Misuzu Baker, Amie Williams-Gray, Caroline H Foltynie, Thomas Goodman, Reyna S Taylor, Craig J Compston, D Alastair S Barker, Roger A Sawcer, Stephen J Goris, An Producer: 20150422 In: Journal of neurology, neurosurgery, and psychiatry vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis. [electronic resource] by Hill-Cawthorne, Grant A Button, Tom Tuohy, Orla Jones, Joanne L May, Karen Somerfield, Jennifer Green, Alison Giovannoni, Gavin Compston, D Alastair S Fahey, Michael T Coles, Alasdair J Producer: 20120328 In: Journal of neurology, neurosurgery, and psychiatry vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients. [electronic resource] by Giovannoni, Gavin Cohen, Jeffrey A Coles, Alasdair J Hartung, Hans-Peter Havrdova, Eva Selmaj, Krzysztof W Margolin, David H Lake, Stephen L Kaup, Susan M Panzara, Michael A Compston, D Alastair S Producer: 20170515 In: Neurology vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy. [electronic resource] by Tuohy, Orla Costelloe, Lisa Hill-Cawthorne, Grant Bjornson, Ingunn Harding, Katharine Robertson, Neil May, Karen Button, Tom Azzopardi, Laura Kousin-Ezewu, Onajite Fahey, Michael T Jones, Joanne Compston, D Alastair S Coles, Alasdair Producer: 20150327 In: Journal of neurology, neurosurgery, and psychiatry vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. [electronic resource] by Jones, Joanne L Anderson, Jane M Phuah, Chia-Ling Fox, Edward J Selmaj, Krzysztof Margolin, David Lake, Stephen L Palmer, Jeffrey Thompson, Sara J Wilkins, Alastair Webber, Daniel J Compston, D Alastair Coles, Alasdair J Producer: 20101007 In: Brain : a journal of neurology vol. 133 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study. [electronic resource] by Wray, Sibyl Havrdova, Eva Snydman, David R Arnold, Douglas L Cohen, Jeffrey A Coles, Alasdair J Hartung, Hans-Peter Selmaj, Krzysztof W Weiner, Howard L Daizadeh, Nadia Margolin, David H Chirieac, Madalina C Compston, D Alastair S Producer: 20200708 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. [electronic resource] by Coles, Alasdair J Fox, Edward Vladic, Anton Gazda, Suzanne K Brinar, Vesna Selmaj, Krzysztof W Bass, Ann Doan-Do Wynn, Daniel R Margolin, David H Lake, Stephen L Moran, Susan Palmer, Jeffrey Smith, M Shelton Compston, D Alastair S Producer: 20110615 In: The Lancet. Neurology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. [electronic resource] by Ismail, Azza Cooper-Knock, Johnathan Highley, J Robin Milano, Antonio Kirby, Janine Goodall, Emily Lowe, James Scott, Ian Constantinescu, Cris S Walters, Stephen J Price, Sian McDermott, Christopher J Sawcer, Stephen Compston, D Alastair S Sharrack, Basil Shaw, Pamela J Producer: 20130222 In: Journal of neurology, neurosurgery, and psychiatry vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS. [electronic resource] by Arnold, Douglas L Fisher, Elizabeth Brinar, Vesna V Cohen, Jeffrey A Coles, Alasdair J Giovannoni, Gavin Hartung, Hans-Peter Havrdova, Eva Selmaj, Krzysztof W Stojanovic, Miroslav Weiner, Howard L Lake, Stephen L Margolin, David H Thomas, David R Panzara, Michael A Compston, D Alastair S Producer: 20170510 In: Neurology vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. [electronic resource] by Coles, Alasdair J Twyman, Cary L Arnold, Douglas L Cohen, Jeffrey A Confavreux, Christian Fox, Edward J Hartung, Hans-Peter Havrdova, Eva Selmaj, Krzysztof W Weiner, Howard L Miller, Tamara Fisher, Elizabeth Sandbrink, Rupert Lake, Stephen L Margolin, David H Oyuela, Pedro Panzara, Michael A Compston, D Alastair S Producer: 20121210 In: Lancet (London, England) vol. 380 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 23 results.